Medical Care
Global Circulating Biomarker for Liquid Biopsy Market Research Report 2025
- Sep 09, 25
- ID: 494307
- Pages: 73
- Figures: 79
- Views: 22
This report aims to provide a comprehensive presentation of the global market for Circulating Biomarker for Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Biomarker for Liquid Biopsy.
The Circulating Biomarker for Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Biomarker for Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Biomarker for Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Segment by Type
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others
Segment by Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Biomarker for Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Circulating Biomarker for Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Biomarker for Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Biomarker for Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Segment by Type
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others
Segment by Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Biomarker for Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2020-2031)
2.2 Global Circulating Biomarker for Liquid Biopsy Growth Trends by Region
2.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Size by Region (2020-2025)
2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2026-2031)
2.3 Circulating Biomarker for Liquid Biopsy Market Dynamics
2.3.1 Circulating Biomarker for Liquid Biopsy Industry Trends
2.3.2 Circulating Biomarker for Liquid Biopsy Market Drivers
2.3.3 Circulating Biomarker for Liquid Biopsy Market Challenges
2.3.4 Circulating Biomarker for Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue
3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2020-2025)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Biomarker for Liquid Biopsy Revenue
3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2024
3.5 Global Key Players of Circulating Biomarker for Liquid Biopsy Head office and Area Served
3.6 Global Key Players of Circulating Biomarker for Liquid Biopsy, Product and Application
3.7 Global Key Players of Circulating Biomarker for Liquid Biopsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Biomarker for Liquid Biopsy Breakdown Data by Type
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2020-2025)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2026-2031)
5 Circulating Biomarker for Liquid Biopsy Breakdown Data by Application
5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2020-2025)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
6.2 North America Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
7.2 Europe Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
8.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
9.2 Latin America Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
9.4 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
10.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.3.5 GE Healthcare Recent Development
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Details
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.4.5 Epigenomics AG Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.6.5 Biocept Recent Development
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.7.5 Affymetrix Recent Development
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Company Details
11.8.2 Fluxion Biosciences Business Overview
11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.8.5 Fluxion Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2020-2031)
2.2 Global Circulating Biomarker for Liquid Biopsy Growth Trends by Region
2.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Size by Region (2020-2025)
2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2026-2031)
2.3 Circulating Biomarker for Liquid Biopsy Market Dynamics
2.3.1 Circulating Biomarker for Liquid Biopsy Industry Trends
2.3.2 Circulating Biomarker for Liquid Biopsy Market Drivers
2.3.3 Circulating Biomarker for Liquid Biopsy Market Challenges
2.3.4 Circulating Biomarker for Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue
3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2020-2025)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Biomarker for Liquid Biopsy Revenue
3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2024
3.5 Global Key Players of Circulating Biomarker for Liquid Biopsy Head office and Area Served
3.6 Global Key Players of Circulating Biomarker for Liquid Biopsy, Product and Application
3.7 Global Key Players of Circulating Biomarker for Liquid Biopsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Biomarker for Liquid Biopsy Breakdown Data by Type
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2020-2025)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2026-2031)
5 Circulating Biomarker for Liquid Biopsy Breakdown Data by Application
5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2020-2025)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
6.2 North America Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
7.2 Europe Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
8.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
9.2 Latin America Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
9.4 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size (2020-2031)
10.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.3.5 GE Healthcare Recent Development
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Details
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.4.5 Epigenomics AG Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.6.5 Biocept Recent Development
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.7.5 Affymetrix Recent Development
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Company Details
11.8.2 Fluxion Biosciences Business Overview
11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
11.8.5 Fluxion Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Circulating Tumor DNA (ctDNA)
Table 4. Key Players of Cell-Free DNA (cfDNA)
Table 5. Key Players of Extracellular Vesicles (EVs)
Table 6. Key Players of Others
Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2020-2025)
Table 11. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2026-2031)
Table 13. Circulating Biomarker for Liquid Biopsy Market Trends
Table 14. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 15. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 16. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 17. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2020-2025)
Table 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2024)
Table 20. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Circulating Biomarker for Liquid Biopsy, Headquarters and Area Served
Table 23. Global Key Players of Circulating Biomarker for Liquid Biopsy, Product and Application
Table 24. Global Key Players of Circulating Biomarker for Liquid Biopsy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2020-2025)
Table 28. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2026-2031)
Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2020-2025)
Table 32. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2026-2031)
Table 34. North America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbott Laboratories Company Details
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product
Table 52. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Becton, Dickinson and Company Company Details
Table 55. Becton, Dickinson and Company Business Overview
Table 56. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product
Table 57. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 58. Becton, Dickinson and Company Recent Development
Table 59. GE Healthcare Company Details
Table 60. GE Healthcare Business Overview
Table 61. GE Healthcare Circulating Biomarker for Liquid Biopsy Product
Table 62. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 63. GE Healthcare Recent Development
Table 64. Epigenomics AG Company Details
Table 65. Epigenomics AG Business Overview
Table 66. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product
Table 67. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 68. Epigenomics AG Recent Development
Table 69. Agilent Technologies Company Details
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product
Table 72. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 73. Agilent Technologies Recent Development
Table 74. Biocept Company Details
Table 75. Biocept Business Overview
Table 76. Biocept Circulating Biomarker for Liquid Biopsy Product
Table 77. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 78. Biocept Recent Development
Table 79. Affymetrix Company Details
Table 80. Affymetrix Business Overview
Table 81. Affymetrix Circulating Biomarker for Liquid Biopsy Product
Table 82. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 83. Affymetrix Recent Development
Table 84. Fluxion Biosciences Company Details
Table 85. Fluxion Biosciences Business Overview
Table 86. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product
Table 87. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 88. Fluxion Biosciences Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Circulating Biomarker for Liquid Biopsy Picture
Figure 2. Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2024 VS 2031
Figure 4. Circulating Tumor Cells (CTCs) Features
Figure 5. Circulating Tumor DNA (ctDNA) Features
Figure 6. Cell-Free DNA (cfDNA) Features
Figure 7. Extracellular Vesicles (EVs) Features
Figure 8. Others Features
Figure 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2024 VS 2031
Figure 11. Early Cancer Screening Case Studies
Figure 12. Therapy Selection Case Studies
Figure 13. Treatment Monitoring Case Studies
Figure 14. Recurrence Monitoring Orthopedics Case Studies
Figure 15. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Region: 2024 VS 2031
Figure 19. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2024
Figure 20. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2024
Figure 22. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 24. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 28. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Region (2020-2031)
Figure 36. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 44. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 48. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 53. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 54. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 55. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 56. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 57. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 58. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Circulating Tumor DNA (ctDNA)
Table 4. Key Players of Cell-Free DNA (cfDNA)
Table 5. Key Players of Extracellular Vesicles (EVs)
Table 6. Key Players of Others
Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2020-2025)
Table 11. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2026-2031)
Table 13. Circulating Biomarker for Liquid Biopsy Market Trends
Table 14. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 15. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 16. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 17. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2020-2025)
Table 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2024)
Table 20. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Circulating Biomarker for Liquid Biopsy, Headquarters and Area Served
Table 23. Global Key Players of Circulating Biomarker for Liquid Biopsy, Product and Application
Table 24. Global Key Players of Circulating Biomarker for Liquid Biopsy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2020-2025)
Table 28. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2026-2031)
Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2020-2025)
Table 32. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2026-2031)
Table 34. North America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbott Laboratories Company Details
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product
Table 52. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Becton, Dickinson and Company Company Details
Table 55. Becton, Dickinson and Company Business Overview
Table 56. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product
Table 57. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 58. Becton, Dickinson and Company Recent Development
Table 59. GE Healthcare Company Details
Table 60. GE Healthcare Business Overview
Table 61. GE Healthcare Circulating Biomarker for Liquid Biopsy Product
Table 62. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 63. GE Healthcare Recent Development
Table 64. Epigenomics AG Company Details
Table 65. Epigenomics AG Business Overview
Table 66. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product
Table 67. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 68. Epigenomics AG Recent Development
Table 69. Agilent Technologies Company Details
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product
Table 72. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 73. Agilent Technologies Recent Development
Table 74. Biocept Company Details
Table 75. Biocept Business Overview
Table 76. Biocept Circulating Biomarker for Liquid Biopsy Product
Table 77. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 78. Biocept Recent Development
Table 79. Affymetrix Company Details
Table 80. Affymetrix Business Overview
Table 81. Affymetrix Circulating Biomarker for Liquid Biopsy Product
Table 82. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 83. Affymetrix Recent Development
Table 84. Fluxion Biosciences Company Details
Table 85. Fluxion Biosciences Business Overview
Table 86. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product
Table 87. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 88. Fluxion Biosciences Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Circulating Biomarker for Liquid Biopsy Picture
Figure 2. Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2024 VS 2031
Figure 4. Circulating Tumor Cells (CTCs) Features
Figure 5. Circulating Tumor DNA (ctDNA) Features
Figure 6. Cell-Free DNA (cfDNA) Features
Figure 7. Extracellular Vesicles (EVs) Features
Figure 8. Others Features
Figure 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2024 VS 2031
Figure 11. Early Cancer Screening Case Studies
Figure 12. Therapy Selection Case Studies
Figure 13. Treatment Monitoring Case Studies
Figure 14. Recurrence Monitoring Orthopedics Case Studies
Figure 15. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Region: 2024 VS 2031
Figure 19. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2024
Figure 20. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2024
Figure 22. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 24. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 28. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Region (2020-2031)
Figure 36. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 44. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Country (2020-2031)
Figure 48. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 53. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 54. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 55. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 56. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 57. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 58. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232